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Abstract
After an acquired brain injury, responses that induce cell death are activated; 
however, neuroprotective mechanisms are also activated. The relation between 
these responses determines the destination of the damaged tissue. This relation 
presents variations throughout the day; numerous studies have shown that the 
onset of a stroke occurs preferably in the morning. In the rat, ischemia causes more 
damage when it is induced during the night. The damage caused by a traumatic 
brain injury (TBI), in the rat, varies depending on the time of day it is induced. 
Minor behavioral damage has been reported when the TBI occurs during the night, 
a period that coincides with the wakefulness of the rat. It also has been observed 
that sleep deprivation accelerates the recovery. Our group has documented that 
this is due, in part, to a difference in the degree of activation of cannabinergic, 
GABAergyc, and glutamatergic systems.
Keywords: circadian rhythm, sleep deprivation, traumatic brain injury, stroke, 
cannabinergic system, glutamatergic system, GABAergyc system
1. Introduction
Recent research on acquired brain injury, the pathophysiological processes 
involved, as well as the mechanisms of morphological and functional recovery, 
have led, among other essential aspects, to the concept of neuroprotection [1]. This 
term refers to the use of any therapeutic modality that prevents or delays cell death 
resulting from a neuronal injury. In this sense, neuroprotection could be considered 
as a cytoprotection technique similar to cardioprotection or vasoprotection [2, 3].
Also, the term neuroprotection has been used to refer to self-protective responses 
that the body displays when it undergoes an acquired brain injury and tries to 
maintain the integrity and functionality of the brain [4]. The management of the 
term neuroprotection, in this sense, is more recent and emphasizes the balance of 
the body’s responses to an event of ischemia and/or traumatic brain injury (TBI).
In a TBI, two types of lesions can be identified. The primary lesion, which 
corresponds to mechanical damage to the parenchyma or the vasculature, occurs 
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at the moment of impact and is not reversible or curable and the secondary lesion, 
which corresponds to late effects, which occur hours to days post-trauma, involves a 
series of functional, structural, cellular, and molecular changes that cause neuronal 
damage. Among the events that occur, ischemia has been described. When the flow 
of blood to the brain tissue ceases, the entry of oxygen and nutrients and the exit 
of potentially toxic metabolites are severely damaged, resulting in biochemical 
changes in the affected brain area. There is a depletion of glucose and glycogen and 
failure of Na/K ATPase and other pumps, which result in a decrease in excitation 
threshold, presence of action potentials, release of excitatory neurotransmitters 
such as glutamate, massive entry of calcium, and activation of proteases, lipases, 
and nucleases, among other enzymes [5]. However, as mentioned earlier, neuropro-
tective responses are also induced; for example, the GABAergic and cannabinergic 
systems are activated [6, 7]. The balance between both responses will determine the 
outcome of the damaged tissue [4].
Indeed, the release of glutamate and the activation of its ionotropic receptors 
are the main events that result in cell death as a consequence of a TBI or cerebral 
ischemic attack with acute hypoxia [8–10]. The increase in GABAergic synaptic 
transmission may have neuroprotective effects against cerebral ischemia, and its 
inhibition increases the alterations induced by this event, while the inhibition of 
excitatory signals or excitatory neurotransmitters results in the cytoprotection of 
ischemic brain tissue [6, 11]. GABA mimetic drugs have a protective effect. Thus, 
administration of GABAA agonists such as benzodiazepines or muscimol attenuates 
the damage produced by a TBI [12, 13], while bicuculline, a GABAA antagonist, 
increases it [12].
In vitro and in vivo data suggest that the cannabinergic system is a component of 
mammalian neuroprotective mechanisms that an organism displays after suffering 
an insult such as a TBI [7, 14–17]. Endocannabinoid anandamide and 2-arachi-
donoylglycerol (2-Ag) increase after an acquired brain injury [14, 15] and serve as 
signaling mediators in integrating inhibitory and excitatory synaptic transmission, 
as they could regulate glutamate and GABA release [17]. Besides, recently it has 
been reported that 2-Ag keeps brain homeostasis by exerting anti-inflammatory 
effects in response to harmful insults [17].
2. Neuroprotection and photoperiod
The cerebral ischemic attack, similar to the heart attack, has a marked diurnal 
rhythm. Numerous studies have shown that the time of onset of cerebral vascular 
accidents, as well as transient ischemic attacks, occurs preferably between 6:00 
and 12:00 h in the morning that is, after the subject gets up and begins to pres-
ent activity [18–20]. Numerous variables have been mentioned as responsible for 
this circadian pattern, among which are postural changes, circadian variations of 
platelet aggregation, thrombolysis, blood pressure, cardiac rhythm, and circulating 
concentrations of catecholamines, whose maximum levels occur just in this period. 
In the rat, ischemia causes more significant damage if it is induced in the hours of 
darkness compared to the hours of light [21].
Our group has analyzed the severity of a TBI concerning the photoperiod. 
Using the rat as a model, we have found that the recovery from a TBI induced by 
the technique of “closed head injury” presents diurnal variations, recovery being 
better if the trauma occurs in the hours of darkness concerning daylight hours 
[22–24]. In other words, there seems to be a greater neuroprotection response in 
the hours of darkness. The fact that the functionality of the brain is not the same 
in the hours of light as in the hours of darkness is not surprising; many pieces of 
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evidence indicate the importance of rhythms in general, and in particular of the 
circadian rhythms in physiology. The presence of circadian rhythms has been 
explained as an adaptive response of the different organisms to the environmental 
variables. All species from cyanobacteria to humans have these rhythms that serve 
to anticipate the daily variations of different variables such as temperature, light, or 
food intake. It is accepted that virtually any physiological parameter that has been 
measured for a period of 24 h in humans has fluctuations [25, 26]. Several aspects 
of brain physiology, neuronal activity, and secretion of neurotransmitters, among 
others, change throughout the day, in such a way that the cerebral functions present 
circadian variations, dependent on the time of day, although it should be noted that 
they also depend on the sleep-wake cycle [27, 28]. Circadian rhythms in mammals 
are generated by the suprachiasmatic nucleus (SCN) of the hypothalamus, and both 
GABA and glutamate are intimately related to the function of this nucleus. Indeed, 
the photic information received by the SCN comes directly from the retina through 
the hypothalamic retinal tract, which releases glutamate, and indirectly through the 
hypothalamic geniculate tract that releases GABA and neuropeptide Y [29]; besides, 
GABA is one of the main neurotransmitters present in the SCN.
The variability in neuroprotection associated with the photoperiod can be 
explained by considering that the endogenous levels of practically any endogenous 
molecule present variations during the different phases of photoperiod. Diurnal 
variations have been reported in the circulating levels of heat shock proteins (HSPs) 
[30], as well as brain-derived neurotrophic factor (BDNF) and its receptors in the 
prefrontal cortex [31], of anandamide in cerebrospinal fluid, pons, hippocampus, 
and hypothalamus [32]. Our group found diurnal variations in CB1 cannabinoid 
receptor expression in the hippocampus [33], pons [34] and cerebral cortex [23]. 
Figure 1. 
Mechanisms of neuronal damage, endogenous neuroprotection, and its relationship with photoperiod, 
sleep deprivation for short periods, and sleep rebound. BDNF: brain-derived neurotrophic factor; CB1: 
cannabinoid receptor type 1; GABA: gamma-aminobutyric acid; HSP: heat shock proteins; NMDA: 
N-methyl-d-aspartate receptor; 2-Ag: 2-arachidonoylglycerol; and SWS: slow wave sleep. Data obtained 
from Refs. [4-7, 23, 24, 31-34, 71-86, 92-95].
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Besides, we recently reported diurnal variations in the expression of the NMDA 
receptor in motor cortex [24] (see Figure 1).
On the other hand, it has been reported that the TBI causes circadian dysregula-
tions of blood pressure, heart rate, body temperature [35], hormonal cycles [36], 
and the sleep-wake cycle [37, 38]. Patients who suffered a severe TBI do not have a 
perceptible sleep/wake rhythm on the first or second day after the injury, and only 
half of them will have recovered a consolidated day/night pattern of wakefulness 
and sleep, 8 days later. The recovery of a circadian organization is a predictive 
factor of patient wellness [39]. It has been suggested that patients with lesions in 
the hypothalamus and the SCN will have poor outcomes [40]. Recent data from the 
literature indicate that even a mild TBI causes damage in hypothalamic structural 
and functional connectivity [41]. Also, it has been shown that the expression of 
clock genes such as BMAL1 and Cry1 is disrupted in the SCN and hippocampus of 
rats that are subjected to TBI [42].
3. Neuroprotection and sleep
Numerous studies have documented sleep-wake disturbances (SWD) in adults 
post-TBI, with excessive diurnal somnolence and insomnia being the biggest com-
plaints. However, other sleep disorders such as narcolepsy, restless leg syndrome, 
parasomnias, and obstructive and central sleep apnea have also been reported [39]. 
Several studies indicate that hypersomnia following TBI has a prevalence varying 
between 50 and 85% [39, 43]. If the onset of hypersomnolence is from the traumatic 
event, it is called posttraumatic hypersomnia (PH) and is a hallmark of severe 
TBI. It has been reported that PH is related to direct injury to the alerting histamin-
ergic tuberomammillary neurons, which are reduced by approximately 40% after 
severe TBI [44]. Also documented are fatigue and hypersomnia following mild TBI 
associated with the injury of the lower portion of the ascending reticular activat-
ing system between the pontine reticular formation and the intralaminar thalamic 
nucleus, using diffusion tensor tractography [45].
Botchway et al. [46] reported that even 20 years after a TBI in childhood, young 
adulthood present increased risk of SWD and that this is more common after a 
moderate TBI than after a severe one.
Haboubi et al. [47] found that up to 46% of patients reported insomnia that 
persisted beyond 6 months after mild TBI. Insomnia is reported more frequently 
with milder forms of TBI injuries [48] and has been associated with head trauma 
involving lower frontal and anterior temporal regions, including the basal forebrain 
as it affects the area involved in sleep initiation [39, 49].
Zhou [41], using advanced quantitative magnetic resonance imaging techniques, 
showed that disruption of functional and structural hypothalamic connectivity in 
patients with mild TBI was associated with fatigue and sleep problems.
Hypersomnolence has been associated with a decrease in the number of hypo-
cretin-positive cells in experimental TBI models [50–52]. Also, an increased number 
of awakenings associated with an increase in reactive microglia in thalamic regions 
have been reported [53].
On the other hand, there are few data in the literature that support the neuro-
protective role of sleep or wakefulness. Although, when a child falls and hits his/
her head, a general recommendation says: “Do not let him sleep”; there is no reliable 
data in the literature to support that this sleep deprivation will have some protec-
tive effect. More informed recommendations indicate that if the child is sleepy, he/
she is allowed to sleep, but that he must be awakened every 2 h to verify that he/she 
speaks, moves the four extremities and that is oriented [54].
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It is worth noting that there is extensive literature that supports that sleep depri-
vation for prolonged periods impairs many physiological functions and causes death 
[55–58]. Total sleep deprivation (TSD) in rats causes deterioration in health whose 
end is death in a period between 11 and 32 days [56], while selectively rapid eye 
movement sleep deprivation (REMSD) causes death between 16 and 54 days [57].
Nevertheless, recent evidence suggests that sleep deprivation for shorter periods 
may be neuroprotective. Indeed, several studies in focal and global cerebral ischemia 
[59, 61, 65–67], cardiac arrest [60] or TBI [64, 68, 69] murine models have documented 
that both TSD [59, 61, 64–66, 69] and REMSD [60, 64, 67] have neuroprotective 
effects, whether they are applied before the insult [59–61, 65, 66] or after it [64, 67, 69] 
as summarized in Table 1. However, some studies indicate that sleep deprivation for 
short periods had no effect [68] or, its effect was deleterious [62, 63] (see Table 1).
As can be seen in Table 1, in some of the cases, sleep deprivation for short periods 
of time was applied before the noxious stimulus so it could be considered as a precon-
ditioning stimulus [70], that is, a stimulus that triggers the activation of the endog-
enous neuroprotection response and prepares the organism against a harmful event 
of greater wingspan. However, in other studies indicated in Table 1, sleep depriva-
tion for short periods was applied after the noxious stimulus, so it would rather act as 
a neuroprotective factor by delaying and/or decreasing the secondary lesion. In this 
sense, several reports in the literature suggest that sleep deprivation for short periods 
increase the expression of neuroprotective molecules like HSP, growth factors, and 
plasticity-related genes [71–73]. It also has been reported that TSD for short periods 
produces neurogenesis in the hippocampus [74, 75] (see Figure 1).
Another factor that could be participating in the neuroprotective role of sleep 
deprivation for short periods is the balance between glutamatergic and GABAergic 
systems, which both sleep deprivation and TBI produce. In the literature, there are 
reports that TBI increases both glutamate [76–78] and GABA [79]. Also, the expres-
sion of GABAA receptors [80, 81] and NMDA [82] is modified; there are also several 
reports that indicate that sleep deprivation for short periods changes the release of 
both glutamate and GABA. REMSD increases the level of glutamate [83], as well 
as that of GABA but reduces the glutamate/GABA ratio [84]. These modifications 
could be significant in events such as TBI or ischemia since they would be regulating 
the excitotoxicity produced by glutamate. They could also be correlated with reports 
showing that sleep deprivation for short periods modifies the expression and/or 
replacement of NMDA receptors [85, 86]. For example, McDermott [87] shows 
that the REMSD for 72 h increases the intracellular NMDA levels, which could be 
interpreted as a down-regulation in response to the increase of glutamate; in the 
same way, several investigations show that the sleep deprivation for short periods 
can be an event that prevents the glutamate toxicity mediated by NMDA receptors 
[88]. As for GABAA receptors, there are reports that sleep deprivation for short 
periods increases their expression [89, 90], and/or modifies the expression of some 
subunits, which may explain functional changes in GABAergic transmission [91].
The cannabinergic system could also be participating in the neuroprotective 
effect of sleep deprivation for short periods. It has been reported that circulating 
2-Ag increases with sleep deprivation [92].
Also, it is worth noting that TSD induces a subsequent increase or rebound in 
slow-wave or high-amplitude electroencephalographic activity during slow wave 
sleep (SWS) while REMD induces an increase or rebound in REMS [93], so it is 
possible that the sleep rebound is the neuroprotective factor. This is in agreement 
with the findings of Brager et al. [94] who utilized remote preconditioning to prevent 
damage in a focal brain ischemia model. They found that remote preconditioning 
was associated with an increase of SWS. Also, sleep rebound appears to reduce the 
cerebral cortex level of glutamate [83] and increase that of GABA [95]. Besides, we 
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have documented that the rebound after REMSD increases the expression of the CB1 
cannabinoid receptors in the rat pons [34], which could have a neuroprotective effect.
Also, during sleep rebound, the function of the glymphatic system is favored 
and therefore the elimination of toxic brain substances [96–98].
Reference Damage 
model
Sleep deprivation (method 
and schedule)
Main findings Outcome
Hsu et al. [59] Global 
cerebral 
ischemia 
in rat
TSD for 5 days before a 
transient global cerebral 
ischemia
Attenuation of the damage of 
pyramidal cells in the hippocampal 
CA1 and glial reactions
⇑
Weil et al. [60] Cardiac 
arrest in 
mice
48 h of REMSD immediately 
before cardiac arrest
Improved ischemic outcome. Lesser 
neuronal hippocampal damage and 
increased gene expression of IL-6 
and IL-10
⇑
Moldovan  
et al. [61]
Focal 
cerebral 
ischemia 
in rat
6 h of TSD immediately 
before focal cerebral 
ischemia
Decreased loss of functions and a 
smaller infarct volume
⇑
Gao et al. [62] Focal 
cerebral 
ischemia 
in rat
TSD for 12 h, 12 h after focal 
cerebral ischemia. TSD for 
12 h, for consecutive 3 days 
12 h after ischemia
Both sleep deprivation schedules 
increased the infarct volume and the 
number of damaged cells
⇓
Zunzunegui 
et al. [63]
Focal 
cerebral 
ischemia 
in rat
TSD for 12 h, for consecutive 
3 days 12 h after ischemia
Lower recovery of forearm motor 
skills, reduction in axonal sprouting, 
and synaptophysin expression
⇓
Martinez Vargas 
et al. [64]
TBI in rat REMSD and TSD for 24 h 
immediately after a  
moderate TBI
Increase in the neurobehavioral 
recovery and reduction in the 
histological damage
⇑
Cam et al. [65] Focal 
cerebral 
ischemia 
in rat
6 h of TSD immediately 
before focal cerebral 
ischemia
Reduction in infarct volume 
associated with an increase in the 
amount of SWS and REMS.
⇑
Pace et al. [66] Focal 
cerebral 
ischemia 
in rat
6 h of TSD immediately 
before focal cerebral 
ischemia
Reduction in infarct volume associated 
with a reduction in up-regulation of 
genes involved in cell cycle regulation 
and immune response.
⇑
Cheng et al. [67] Global 
cerebral 
ischemia 
in rat
REMSD for 12 h/day for 
3 days 48 h after global 
cerebral ischemia and 
reperfusion
Improvement in cognitive function, 
increased number of BrdU- and 
BrdU/NSE-positive cells as well as 
hippocampal BDNF expression
⇑
Caron and 
Stephenson [68]
TBI in rat TSD for 48 h or chronic sleep 
restriction (6 h of sleep/
day for 10 days) following 
mild TBI
TSD or CSR did not exacerbate the 
neuronal damage induced by TBI
=
Morawska  
et al. [69]
TBI in rat Increased sleep with 
sodium oxybate or TSD 
(6 h daily/5 d) starting 
1 day after TBI
Enhanced encephalographic slow-
wave activity. Markedly reduced 
diffuse axonal damage in the cortex 
and hippocampus, and improved 
memory impairment
⇑
SWS, slow wave sleep; REMS, rapid eye movement sleep; TBI, traumatic brain injury; and CSR, Chronic sleep restriction.
Table 1. 
REMSD, rapid eye movement sleep deprivation. TSD, total sleep deprivation.
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4. Sleep deprivation in humans
The TSD or REMSD data for short periods indicated in the previous section were 
obtained in animal models, but what is known in humans?
Recent studies indicate that our society is sleeping less and less and that this 
has a negative impact on health and wellbeing. Between 7 and 8 h/night of sleep is 
recommended in adults, although this time varies from person to person. Having 
an insufficient sleep in quantity or quality for multiple nights causes a debt of sleep 
that cannot be recovered and increases the risk of stroke, obesity, diabetes Mellitus 
type 2, and cardiovascular disease [99].
However, numerous studies have reported the effectiveness of TSD for one night 
in patients with depression; the first to report this were Pflug and Tolle, in 1971 
[100]. Subsequently, Vogel et al. [101] described that the REMSD was also effec-
tive. Gillin [102], in 1983, pointed out that of a total of 852 patients who were TSD 
or REMSD for one or more nights, 493 (57.9%) were reported to have “improved”, 
but it is recognized that this improvement in mood is transient and it is currently 
recommended that the TSD or REMSD be combined with sleep phase advance 
(SPA), pharmacotherapy, and sometimes also phototherapy [103].
Several studies have tried to find the mechanism by which the TSD or REMSD 
are effective in mood improvement. In this sense, some of the effects of sleep depri-
vation or the rebound could be considered as neuroprotective; for example, Davies 
et al. observed that TSD for 24 h increases the serum levels of tryptophan, taurine, 
and serotonin, which could explain, in part, the antidepressant effect of depriva-
tion [104]. It is worth noting that taurine has been related to cell volume changes 
triggered by different neurological diseases that produce secondary damage to 
ischemia [105]. This role is associated with its participation as osmolyte, which has 
been demonstrated by characterizing the increase in its extracellular concentration 
and its decrease in the intracellular one. Taurine can regulate the edema induced by 
the glutamate released during the excitotoxic cascade after a TBI. The nonvesicular 
release of taurine is an essential protective mechanism to prevent cell lysis, since, 
upon release to the extracellular environment, there is a change in the direction of 
mobilization of ions and water [106].
Hefti et al. [107] showed an increased expression of mGluR5 glutamate recep-
tor in the cingulate cortex, insula, medial temporal lobe, parahippocampal gyrus, 
striatum, and amygdala of healthy men after 33 h of TSD. Previously, some authors 
had reported that the activation of this receptor decreases the damage, using animal 
models of cerebral focal ischemia [108] and spinal cord injury [109].
Gorgulu and Caliyurt [110] demonstrated an increase in the concentration of 
serum BDNF in patients with depression treated with three overnight TSD over a 
week; nevertheless, in healthy subjects, TSD did not affect the level of BDNF.
In the course of TSD, the concentration of cortisol increases considerably as a 
result of stimulation of the hypothalamic-pituitary-adrenal axis. The rebound after 
TSD resulted in a significant reduction of cortisol and increase of growth hormone 
(GH) secretion driven by the increase of SWS [111]. Recently, neuroprotection has 
been identified as one of the functions of GH [112, 113].
Also, the level of thyroid hormones increases during sleep deprivation. It is the 
result of the stimulation of the hypothalamic-pituitary-thyroid axis [114]. It has 
also been described that thyroid hormones play a neuroprotective role in acute 
cerebrovascular disorders [115].
However, some studies show effects of TSD that could not be considered as 
neuroprotective; for example, Trivedi et al. [116] found that glutathione, ATP, 
cysteine, and homocysteine levels in plasma were significantly reduced as a result 
of one night of TSD, while Meier-Ewert et al. [117] reported that one night of TSD 
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increased serum C reactive protein concentrations. Also, one night of TSD causes an 
increase of serum concentration of interleukin 6 (IL-6), a proinflammatory cyto-
kine in depressive patients as in healthy subjects; but in healthy individuals sleep 
rebound increased the level of interleukin-1-receptor antagonist (IL-1RA) [118], 
which inhibits the action of the proinflammatory interleukins 1alpha and 1beta.
Some deleterious effects attributed to the TSD may be influenced by the depri-
vation method; for example, Gil-Lozano et al. [119] reported that overnight TSD 
with nocturnal light exposure disrupted the melatonin and cortisol profiles and 
increased insulin resistance. These alterations were not observed in TSD partici-
pants maintained under dark conditions.
5. Limitations
Studies on the impact of acute sleep deprivation and its neuroprotective effects 
in humans against acquired brain damage are scarce. However, studies performed in 
subjects without brain injury indicate the existence of neuroprotective mechanisms, 
as long as it is a TSD for short or acute periods (24 h). In order to propose sleep 
deprivation as a neuroprotective mechanism and incorporate it as part of the treat-
ment against TBI, more studies are still needed.
6. Perspectives
The importance of the TBI as a public health problem worldwide requires us to 
understand the pathophysiological changes underlying this neurological event, as 
well as the processes that favor the activation of endogenous neuroprotection, in 
order to apply them as a possible therapeutic strategy.
The previous evidence highlights the importance of considering the time 
of the day when acquired brain injury is established. The alterations found as a 
consequence of this event are heterogeneous and complex, ranging from molecular 
changes to behavioral modifications; as pointed before, TBI causes dysregulation 
of sleep-wake cycle and homeostasis unbalance including many neuropeptide and 
hormones changes.
In many of the alterations induced by an acquired brain damage, the participa-
tion of neurotransmission systems such as GABAergic, glutamatergic, and can-
nabinergic is fundamental. These, like all endogenous molecules, have a diurnal 
variation; such variations, in the same way, affect the sleep-wake cycle. Evidence in 
animal models of the neuroprotective effect of sleep deprivation for short periods 
encourages us to continue researching this.
Knowing the relationship between neuroprotection, photoperiod, and sleep, 
as well as the participation of the neurotransmission systems involved in the TBI, 
opens a window in their study as potential biomarkers or therapeutic targets. With 
this approach, it will probably benefit a higher number of patients with acquired 
brain damage.
Acknowledgements
This work was supported by PAPIIT IN223417.
9© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
Neuroprotection, Photoperiod, and Sleep
DOI: http://dx.doi.org/10.5772/intechopen.85013
Author details
Marina Martinez-Vargas, Mercedes Graciela Porras-Villalobos,  
Francisco Estrada-Rojo, Ricardo Jesus Martinez-Tapia, Adan Perez-Arredondo, 
Antonio Barajas-Martinez and Luz Navarro*
Department of Physiology, Faculty of Medicine, National Autonomous University 
of Mexico, Cd. Mx., Mexico
*Address all correspondence to: lnavarro@unam.mx
10
Traumatic Brain Injury - Neurobiology, Diagnosis and Treatment
References
[1] LetechipIa-Vallejo G, Morali 
de la Brena G, Cervantes-Alfaro 
JM. Neuroprotección. Neuroprotectores 
endogenos. In: Velazquez-Moctezuma J, 
editor. Temas Selectos de Neurociencias. 
Mexico D.F.: UAM; 2004. pp. 159-168
[2] Leonard AL. History of 
neuroprotection and rationale 
as a therapy for glaucoma. The 
American Journal of Managed Care. 
2008;14:S11-S14
[3] Jain KK. Handbook of 
Neuroprotection. Basel: Humana Press; 
2011. p. 1
[4] Leker RR, Shohami E. Cerebral 
ischemia and trauma-different 
etiologies yet similar mechanisms: 
Neuroprotective opportunities. Brain 
Research Reviews. 2002;39:55-73
[5] Nestler EJ et al. Seizures and stroke. 
In: Molecular Neuropharmacology. A 
Foundation for Clinical Neuroscience. 
NY: McGraw-Hill; 2000. pp. 479-503
[6] Lee JM, Grabb MC, Zipfel GJ, Choi 
DW. Brain tissue responses to ischemia. 
The Journal of Clinical Investigation. 
2000;106(6):723-731
[7] Shohami E, Cohen-Yeshurun 
A, Magid L, Algali M, Mechoulam 
R. Endocannabinoids and traumatic 
brain injury. British Journal of 
Pharmacology. 2011;163(7):1402-1410. 
DOI: 10.1111/j.1476-5381.2011.01343.x
[8] Lyden PD. GABA and 
neuroprotection. International Review 
of Neurobiology. 1997;40:233-258
[9] Grewer C, Gameiro A, Zhang Z, 
Tao Z, Braams S, Rauen T. Glutamate 
forward and reverse transport: From 
molecular mechanism to transporter-
mediated release after ischemia. IUBMB 
Life. 2008;60(9):609-619. DOI: 10.1002/
iub.98
[10] Gouix E, Lèveillè F, Nicole O, Melon 
C, Had-Aissouni L, Buisson A. Reverse 
glial glutamate uptake triggers neuronal 
cell death through extrasynaptic 
NMDA receptor activation. Molecular 
and Cellular Neurosciences. 
2009;40(4):463-473
[11] Zoghbi HY et al. Neurobiology 
of disease. Current Opinion in 
Neurobiology. 2000;10:655-660
[12] OíDell DM et al. Positive and 
negative modulation of the GABA 
receptor and outcome after a traumatic 
brain injury in rats. Brain Research. 
2000;861:325-332
[13] Xu J et al. Additive neuroprotection 
of GABA A and GABA B receptor 
agonists in cerebral ischemic injury via 
PI-3K/Akt pathway inhibiting the ASK1-
JNK cascade. Neuropharmacology. 
2008;54:1029-1040
[14] Panikashvili D, Simeonidou C, 
Ben-Shabat S, Hanus L, Breuer A, 
Mechoulam R, et al. An endogenous 
cannabinoid (2-AG) is neuroprotective 
after brain injury. Nature. 
2001;413:527-531
[15] Mechoulam R, Spatz M, 
Shohami E. Endocannabinoids and 
neuroprotection. Science's STKE. 
2002;2002(129):re5
[16] Mechoulam R. Discovery of 
endocannabinoids and some random 
thoughts on their possible roles in 
neuroprotection and aggression. 
Prostaglandins, Leukotrienes 
and Essential FattyAcids. 
2002;66(2&3):93-99
[17] Xu JY, Chen C. Endocannabinoids in 
synaptic plasticity and neuroprotection. 
The Neuroscientist. 2015;21(2):152-168. 
DOI: 10.1177/1073858414524632
[18] Marler J. Circadian variation in 
stroke onset. In: Deedwania PC, editor. 
11
Neuroprotection, Photoperiod, and Sleep
DOI: http://dx.doi.org/10.5772/intechopen.85013
Circadian Rhythms of Cardiovascular 
Disorders. Armonk, NY: Futura 
Publishing Co Inc.; 1993. pp. 163-172
[19] Chaturvedi S, Adams HP Jr, 
Woolson RF. Circadian variation in 
ischemic stroke subtypes. Stroke. 
1999;30(9):1792-1795
[20] Raj K, Bhatia R, Prasad K, 
Srivastava MV, Vishnubhatla S, Singh 
MB. Seasonal differences and circadian 
variation in stroke occurrence and 
stroke subtypes. Journal of Stroke 
and Cerebrovascular Diseases. 
2015;24(1):10-16. DOI: 10.1016/j.
jstrokecerebrovasdis.2014.07.051
[21] Vinall PE, Kramer MS, Heinel LA, 
Rosenwasser RH. Temporal changes in 
sensitivity of rats to cerebral ischemic 
insult. Journal of Neurosurgery. 
2000;93:82-89
[22] Martinez-Vargas M, Gonzalez-
Rivera R, Soto-Nuñez M, Cisneros-
Martinez M, Huerta-Saquero A, 
Morales-Gomez J, et al. Recovery 
after a traumatic brain injury depends 
on diurnal variations. Effect of 
cystatin C. Neuroscience Letters. 
2006;400:21-24
[23] Martinez-Vargas M, Morales-Gomez 
J, Gonzalez-Rivera R, Hernandez-
Enriquez C, Perez-Arredondo A, 
Estrada-Rojo F, et al. Does the 
neuroprotective role of anandamide 
display diurnal variations? International 
Journal of Molecular Sciences. 
2013;14(12):23341-23355. DOI: 10.3390/
ijms141223341
[24] Estrada-Rojo F, Morales-Gomez J, 
Coballase-Urrutia E, Martinez-Vargas 
M, Navarro L. Diurnal variation of 
NMDA receptor expression in the 
rat cerebral cortex is associated with 
traumatic brain injury damage. BMC 
Research Notes. 2018;11(1):150. DOI: 
10.1186/s13104-018-3258-0
[25] Gruart A, Delgado JM, Escobar C,  
Aguilar-Roblero R. Los relojes que 
gobiernan la vida. In: La ciencia para 
todos 188. México, D.F.: Fondo de 
Cultura Economica; 2002
[26] Jagannath A, Taylor L, Wakaf Z, 
Vasudevan SR, Foster RG. The genetics 
of circadian rhythms, sleep, and 
health. Human Molecular Genetics. 
2017;26(R2):R128-R138. DOI: 10.1093/
hmg/ddx240
[27] Valdez P, Ramirez C, Garcia A, 
Talamantes J. Los cambios en la atención 
a lo largo del día. Ciencia. 2008;59:14-23
[28] Leproult R, Persson PB. Enhanced 
mental performance at higher body 
temperature? American Journal of 
Physiology. Regulatory, Integrative 
and Comparative Physiology. 
2002;283:R1368-R1369
[29] Akiyama M, Moriya T, Shibata 
S. Physiological, pharmacological 
and molecular aspects of mammalian 
biological clocks. Nippon Yakurigaku 
Zasshi. 1998;112:243-250
[30] Sandström ME, Madden LA, Taylor 
L, Siegler JC, Lovell RJ, Midgley A, et al. 
Variation in basal heat shock protein 
70 is correlated to core temperature 
in human subjects. Amino Acids. 
2009;37(2):279-284. DOI: 10.1007/
s00726-008-0144-4
[31] Coria-Lucero CD, Golini RS, 
Ponce IT, Deyurka N, Anzulovich AC, 
Delgado SM, et al. Rhythmic BDNF 
and TrkB expression patterns in the 
prefrontal cortex are lost in aged rats. 
Brain Research. 2016;1653:51-58. DOI: 
10.1016/j.brainres.2016.10.019
[32] Murillo-Rodriguez E, Desarnaud F, 
Prospero-Garcia O. Diurnal variation 
of arachidonoylethanolamine, 
palmitoylethanolamide and 
oleoylethanolamide in the brain of the 
rat. Life Sciences. 2006;79(1):30-37
[33] Rueda-Orozco PE, Soria-Gomez E, 
Montes-Rodriguez CJ, Martinez-Vargas M, 
Galicia O, Navarro L, et al. A potential 
Traumatic Brain Injury - Neurobiology, Diagnosis and Treatment
12
function of endocannabinoids in the 
selection of a navigation strategy 
by rats. Psychopharmacology. 
2008;198(4):565-576
[34] Martínez-Vargas M, Murillo-
Rodríguez E, Gonz·lez-Rivera R, 
Landa A, Méndez-Diaz M, Prospero-
García O, et al. Sleep modulates 
cannabinoid receptor 1 expression 
in the pons of rats. Neuroscience. 
2003;117(1):197-201
[35] Paul T, Lemmer B. Disturbance of 
circadian rhythms in analgosedated 
intensive care unit patients with 
and without craniocerebral injury. 
Chronobiology International. 
2007;24:45-61
[36] Llompart-Pou J, Perez G, Raurich 
JM, Riesco M, Brell M, IbaÒez J, et al. 
Loss of cortisol circadian rhythm in 
patients with traumatic brain injury: A 
microdialysis evaluation. Neurocritical 
Care. 2010;13:211-216
[37] Ayalon L, Borodkin K, Dishon 
L, Kanety H, Dagan Y. Circadian 
rhythm sleep disorders following mild 
traumatic brain injury. Neurology. 
2007;8:1136-1140
[38] Castriotta RJ, Murthy JN. Sleep 
disorders in patients with traumatic 
brain injury: A review. CNS Drugs. 
2010;25:175-185
[39] Wolfe LF, Sahni AS, Attarian 
H. Sleep disorders in traumatic 
brain injury. NeuroRehabilitation. 
2018;43(3):257-266. DOI: 10.3233/
NRE-182583
[40] Duclos C, Dumont M, Blais H, 
Paquet J, Laflamme E, de Beaumont L, 
et al. Rest-activity cycle disturbances 
in the acute phase of moderate 
to severe traumatic brain injury. 
Neurorehabilitation and Neural 
Repair. 2014;28(5):472-482. DOI: 
10.1177/1545968313517756
[41] Zhou Y. Abnormal structural and 
functional hypothalamic connectivity 
in mild traumatic brain injury. Journal 
of Magnetic Resonance Imaging. 
2017;45(4):1105-1112. DOI: 10.1002/
jmri.25413
[42] Boone DR, Sell SL, Micci MA, 
Crookshanks JM, Parsley M, Uchida T, 
et al. Traumatic brain injury-induced 
dysregulation of the circadian clock. 
PLoS One. 2012;7:e46204
[43] Mathias JL, Alvaro PK. Prevalence 
of sleep disturbances, disorders, and 
problems following traumatic brain 
injury: A meta-analysis. Sleep Medicine. 
2012;13(7):898-905. DOI: 10.1016/j.
sleep.2012.04.006
[44] Valko PO, Gavrilov YV, Yamamoto 
M, Finn K, Reddy H, Haybaeck 
J, et al. Damage to histaminergic 
tuberomammillary neurons and other 
hypothalamic neurons with traumatic 
brain injury. Annals of Neurology. 
2015;77(1):177-182. DOI: 10.1002/
ana.24298
[45] Jang SH, Kwon HG. Injury of the 
ascending reticular activating system in 
patients with fatigue and hypersomnia 
following mild traumatic brain injury: 
Two case reports. Medicine (Baltimore). 
2016;95(6):e2628. DOI: 10.1097/
MD.0000000000002628
[46] Botchway EN, Godfrey C, Anderson 
V, Nicholas CL, Catroppa C. Outcomes 
of subjective sleep-wake disturbances 
twenty years after traumatic brain 
injury in childhood. Journal of 
Neurotrauma. 2019;36(5):669-678. DOI: 
10.1089/neu.2018.5743
[47] Haboubi NH, Long J, Koshy M, 
Ward AB. Short-term sequelae of minor 
head injury (6 years experience of 
minor head injury clinic). Disability and 
Rehabilitation. 2001;23(14):635-638
[48] Kaufman Y, Tzischinsky O, 
Epstein R, Etzioni A, Lavie P, Pillar G. 
13
Neuroprotection, Photoperiod, and Sleep
DOI: http://dx.doi.org/10.5772/intechopen.85013
Long-term sleep disturbances in 
adolescents after minor head injury. 
Pediatric Neurology. 2001;24(2):129-134
[49] Viola-Saltzman M, Watson 
NF. Traumatic brain injury and 
sleep disorders. Neurologic Clinics. 
2012;30(4):1299-1312. DOI: 10.1016/j.
ncl.2012.08.008
[50] Rowe RK, Harrison JL, Morrison 
H, Subbian V, Murphy SM, Lifshitz 
J. Acute post-traumatic sleep may 
define vulnerability to a second 
traumatic brain injury in mice. Journal 
of Neurotrauma. 18 Dec 2018. DOI: 
10.1089/neu.2018.5980
[51] Skopin MD, Kabadi SV, Viechweg 
SS, Mong JA, Faden AI. Chronic 
decrease in wakefulness and 
disruption of sleep-wake behavior 
after experimental traumatic brain 
injury. Journal of Neurotrauma. 
2015;32(5):289-296. DOI: 10.1089/
neu.2014.3664
[52] Thomasy HE, Opp MR. Hypocretin 
mediates sleep and wake disturbances 
in a mouse model of traumatic brain 
injury. Journal of Neurotrauma. 
2019;36(5):802-814. DOI: 10.1089/
neu.2018.5810
[53] Hazra A, Macolino C, Elliott MB, 
Chin J. Delayed thalamic astrocytosis 
and disrupted sleep-wake patterns 
in a preclinical model of traumatic 
brain injury. Journal of Neuroscience 
Research. 2014;92(11):1434-1445. DOI: 
10.1002/jnr.23430
[54] Gudeman SK. Textbook of Head 
Injury. Philadelphia: Saunders; 1989
[55] Barriga C, Rodriguez A, Esteban 
S, Rial R. Interrelations between sleep 
and the immune status. Revista de 
Neurologia. 2005;40:548-556
[56] Everson CA, Bergmann BB, 
Rechtschaffen A. Sleep deprivation 
in the rat: III. Total sleep deprivation. 
Sleep. 1989;12:13-21
[57] Kushida CA, Bergmann BM, 
Rechtschaffen A. Sleep deprivation 
in the rat: IV. Paradoxical sleep 
deprivation. Sleep. 1989;12:22-30
[58] Rechtschaffen A, Gilliland 
MA, Bergmann BM, Winter 
JB. Physiological correlates of prolonged 
sleep deprivation in rats. Science. 
1983;221:182-184
[59] Hsu JC, Lee YS, Chang CN, Ling 
EA, Lan CT. Sleep deprivation prior 
to transient global cerebral ischemia 
attenuates glial reaction in the rat 
hippocampal formation. Brain Research. 
2003;984:170-181
[60] Weil ZM, Norman GJ, Karelina 
K, Morris JS, Barker JM, Su AJ, 
et al. Sleep deprivation attenuates 
inflammatory responses and ischemic 
cell death. Experimental Neurology. 
2009;218:129-136
[61] Moldovan M, Constantinescu AO, 
Balseanu A, Oprescu N, Zagrean L, 
Popa-Wagner A. Sleep deprivation 
attenuates experimental stroke severity 
in rats. Experimental Neurology. 
2010;222:135-143
[62] Gao B, Cam E, Jaeger H, 
Zunzunegui C, Sarnthein J, Bassetti 
CL. Sleep disruption aggravates 
focal cerebral ischemia in the rat. 
Sleep. 2010;33:879-887
[63] Zunzunegui C, Gao B, Cam E, 
Hodor A, Bassetti CL. Sleep disturbance 
impairs stroke recovery in the rat. 
Sleep. 2011;34:1261-1269
[64] Martinez-Vargas M, Estrada Rojo 
F, Tabla-Ramon E, Navarro-Arguelles 
H, Ortiz-Lailzon N, Hernandez-
Chavez A, et al. Sleep deprivation has a 
neuroprotective role in a traumatic brain 
injury of the rat. Neuroscience Letters. 
2012;529(2):118-122. DOI: 10.1016/j.
neulet.2012.09.037
[65] Cam E, Gao B, Imbach L, Hodor 
A, Bassetti CL. Sleep deprivation 
Traumatic Brain Injury - Neurobiology, Diagnosis and Treatment
14
before stroke is neuroprotective: A 
pre-ischemic conditioning related to 
sleep rebound. Experimental Neurology. 
2013;247:673-679. DOI: 10.1016/j.
expneurol.2013.03.003
[66] Pace M, Baracchi F, Gao B, Bassetti 
C. Identification of sleep-modulated 
pathways involved in neuroprotection 
from stroke. Sleep. 2015;38(11): 
1707-1718. DOI: 10.5665/sleep.5148
[67] Cheng O, Li R, Zhao L, Yu L, Yang 
B, Wang J, et al. Short-term sleep 
deprivation stimulates hippocampal 
neurogenesis in rats following global 
cerebral ischemia/reperfusion. PLoS 
One. 2015;10(6):e0125877. DOI: 10.1371/
journal.pone.0125877
[68] Caron AM, Stephenson R. Sleep 
deprivation does not affect neuronal 
susceptibility to mild traumatic brain 
injury in the rat. Nature and Science of 
Sleep. 2015;7:63-72. DOI: 10.2147/NSS.
S82888
[69] Morawska MM, Büchele F, 
Moreira CG, Imbach LL, Noain D, 
Baumann CR. Sleep modulation 
alleviates axonal damage and cognitive 
decline after rodent traumatic brain 
injury. The Journal of Neuroscience. 
2016;36(12):3422-3429. DOI: 10.1523/
JNEUROSCI.3274-15.2016
[70] Pincherle A, Pace M, Sarasso S, 
Facchin L, Dreier JP, Bassetti CL. Sleep, 
preconditioning and stroke. Stroke. 
2017;48(12):3400-3407. DOI: 10.1161/
STROKEAHA.117.018796
[71] Tononi G, Cirelli C. Modulation 
of brain gene expression during sleep 
and wakefulness: A review of recent 
findings. Neuropsychopharmacology. 
2001;25(Suppl):S28-S35
[72] Cirelli C, Gutierrez CM, Tononi 
G. Extensive and divergent effects of 
sleep and wakefulness on brain gene 
expression. Neuron. 2004;41(1):35-43
[73] Elliott AS, Huber JD, OíCallaghan 
JP, Rosen CL, Miller DB. A review of 
sleep deprivation studies the brain 
transcriptome. Springerplus. 2014;3:728
[74] Grassi Zucconi G, Cipriani S, 
Balgkouranidou I, Scattoni R. One 
night sleep deprivation stimulates 
hippocampal neurogenesis. Brain 
Research Bulletin. 2006;69:375-381
[75] Junek A, Rusak B, Semba K. Short-
term sleep deprivation may alter 
the dynamics of hippocampal cell 
proliferation in adult rats. Neuroscience. 
2010;170:1140-1152
[76] Faden AI, Demediuk P, Panter 
SS, Vink R. The role of excitatory 
amino acids and NMDA receptors 
in traumatic brain injury. Science. 
1989;244(4906):798-800
[77] Katayama Y, Becker DP, Tamura 
T, Hovda DA. Massive increases 
in extracellular potassium and the 
indiscriminate release of glutamate 
following concussive brain injury. 
Journal of Neurosurgery. 1990 
Dec;73(6):889-900
[78] Globus MY, Alonso O, Dietrich 
WD, Busto R, Ginsberg MD. Glutamate 
release and free radical production 
following brain injury: Effects of 
posttraumatic hypothermia. Journal of 
Neurochemistry. 1995;65(4):1704-1711
[79] Zhong C et al. NAAG peptidase 
inhibitor increases dialysate NAAG 
and reduces glutamate, aspartate and 
GABA levels in the dorsal hippocampus 
following fluid percussion injury in 
the rat. Journal of Neurochemistry. 
2006;97(4):1015-1025
[80] Neumann-Haefelin T et al. 
Upregulation of GABA-receptor a1- and 
a2-subunit mRNAs following a ischemic 
cortical lesions in rats. Brain Research. 
1999;816:234-237
[81] Mtchedlishvili Z, Lepsveridze E, 
Xu H, Kharlamov EA, Lu B, Kelly KM. 
15
Neuroprotection, Photoperiod, and Sleep
DOI: http://dx.doi.org/10.5772/intechopen.85013
Increase of GABAA receptor-
mediated tonic inhibition in dentate 
granule cells after traumatic brain 
injury. Neurobiology of Disease. 
2010;38(3):464-475. DOI: 10.1016/j.
nbd.2010.03.012
[82] Kumar A, Zou L, Yuan X, Long Y, 
Yang K. N-methyl-d-aspartate receptors: 
Transient loss of NR1/NR2A/NR2B 
subunits after traumatic brain injury in 
a rodent model. Journal of Neuroscience 
Research. 2002;67(6):781-786
[83] Dash MB, Douglas CL, Vyazovskiy 
VV, Cirelli C, Tononi G. Long-term 
homeostasis of extracellular glutamate 
in the rat cerebral cortex across sleep 
and waking states. The Journal of 
Neuroscience. 2009;29(3):620-629. DOI: 
10.1523/JNEUROSCI.5486-08.2009
[84] Wang SX, Li QS. Effects of sleep 
deprivation on gamma-amino-butyric 
acid and glutamate contents in rat 
brain. Di Yi Jun Yi Da Xue Xue Bao. 
2002;22(10):888-890
[85] Longordo F et al. Consequences of 
sleep deprivation on neurotransmitter 
receptor expression and function. The 
European Journal of Neuroscience. 
2009;29(9):1810-1819
[86] Longordo F et al. NR2A at 
CA1 synapses is obligatory for 
the susceptibility of hippocampal 
plasticity to sleep loss. The Journal of 
Neuroscience. 2009;29(28):9026-9041
[87] McDermott CM et al. Sleep 
deprivation-induced alterations in 
excitatory synaptic transmission in the 
CA1 region of the rat hippocampus. 
The Journal of Physiology. 2006;570 
(Pt 3):553-565
[88] Novati A, Hulshof HJ, Granic 
I, Meerlo P. Chronic partial 
sleep deprivation reduces brain 
sensitivity to glutamate N-methyl-
d-aspartate receptor-mediated 
neurotoxicity. Journal of Sleep 
Research. 2012;21(1):3-9. DOI: 
10.1111/j.1365-2869.2011.00932.x
[89] Pokk P et al. Is upregulation 
of benzodiazepine receptors a 
compensatory reaction to reduced 
GABAergic tone in the brain of stressed 
mice? Naunyn-Schmiedeberg's Archives 
of Pharmacology. 1996;354(6):703-708
[90] Cirelli C, Tononi G. Gene 
expression in the brain across the 
sleep-waking cycle. Brain Research. 
2000;885(2):303-321
[91] Modirrousta M, Mainville L, Jones 
BE. Dynamic changes in GABAA 
receptors on basal forebrain cholinergic 
neurons following sleep deprivation and 
recovery. BMC Neuroscience. 2007;8:15
[92] Hanlon EC, Tasali E, Leproult 
R, Stuhr KL, Doncheck E, de Wit 
H, et al. Sleep restriction enhances 
the daily rhythm of circulating 
levels of endocannabinoid 
2-arachidonoylglycerol. 
Sleep. 2016;39(3):653-664. DOI: 
10.5665/sleep.5546
[93] Rechtschaffen A, Bergmann BM, 
Gilliland MA, Bauer K. Effects of 
method, duration, and sleep stage on 
rebounds from sleep deprivation in the 
rat. Sleep. 1999;22(1):11-31
[94] Brager AJ, Yang T, Ehlen JC, 
Simon RP, Meller R, Paul KN. Sleep is 
critical for remote preconditioning-
induced neuroprotection. 
Sleep. 2016;39(11):2033-2040
[95] Bettendorff L et al. Paradoxical 
sleep deprivation increases the content 
of glutamate and glutamine in rat 
cerebral cortex. Sleep. 1996;19(1):65-71
[96] Jessen NA, Munk AS, Lundgaard I, 
Nedergaard M. The glymphatic system: 
A Beginner's guide. Neurochemical 
Research. 2015;40(12):2583-2599. DOI: 
10.1007/s11064-015-1581-6
Traumatic Brain Injury - Neurobiology, Diagnosis and Treatment
16
[97] Rasmussen MK, Mestre H, 
Nedergaard M. The glymphatic pathway 
in neurological disorders. Lancet 
Neurology. 2018;17(11):1016-1024. 
10.1016/S1474-4422(18)30318-1
[98] Eugene AR, Masiak J. The 
neuroprotective aspects of sleep. 
MEDtube Science. 2015;3(1):35-40
[99] Abrams RM. Sleep deprivation. 
Obstetrics and Gynecology Clinics of 
North America. 2015;42(3):493-506. 
DOI: 10.1016/j.ogc.2015.05.013
[100] Pflug B, Tőlle R. Therapie 
endogener depressionen durch 
schlafentzug. Nervenarzt. 
1971;42:117-124
[101] Vogel GW, Vogel F, McAbee 
RS, Thurmond AJ. Improvement of 
depression by REM sleep deprivation, 
new findings and a theory. Archives of 
General Psychiatry. 1980;37:247-253
[102] Gillin JC. The sleep therapies 
of depression. Progress in Neuro-
Psychopharmacology & Biological 
Psychiatry. 1983;7:351-364
[103] Dopierała E, Rybakowski 
J. Sleep deprivation as a method 
of chronotherapy in the treatment 
of depression. Psychiatria Polska. 
2015;49(3):423-433. DOI: 10.12740/
PP/30455
[104] Davies SK, Ang JE, Revell VL, 
Holmes B, Mann A, Robertson FP, 
et al. Effect of sleep deprivation on 
the human metabolome. Proceedings 
of the National Academy of Sciences 
of the United States of America. 
2014;111(29):10761-10766. DOI: 
10.1073/pnas.1402663111
[105] Nilsson P, Hillered L, Pontén 
U, Ungerstedt U. Changes in cortical 
extracellular levels of energy-related 
metabolites and amino acids following 
concussive brain injury in rats. Journal 
of Cerebral Blood Flow and Metabolism. 
1990;10(5):631-637
[106] Stover JF, Unterberg AW. Increased 
cerebrospinal fluid glutamate and 
taurine concentrations are associated 
with traumatic brain edema 
formation in rats. Brain Research. 
2000;875(1-2):51-55
[107] Hefti K, Holst SC, Sovago J, 
Bachmann V, Buck A, Ametamey SM, 
et al. Increased metabotropic glutamate 
receptor subtype 5 availability 
in human brain after one night 
without sleep. Biological Psychiatry. 
2013;73(2):161-168. DOI: 10.1016/j.
biopsych.2012.07.030
[108] Bao WL, Williams AJ, Faden 
AI, Tortella FC. Selective mGluR5 
receptor antagonist or agonist provides 
neuroprotection in a rat model of focal 
cerebral ischemia. Brain Research. 
2001;922(2):173-179
[109] Byrnes KR, Stoica B, Riccio 
A, Pajoohesh-Ganji A, Loane DJ, 
Faden AI. Activation of metabotropic 
glutamate receptor 5 improves recovery 
after spinal cord injury in rodents. 
Annals of Neurology. 2009;66(1):63-74. 
DOI: 10.1002/ana.21673
[110] Gorgulu Y, Caliyurt O. Rapid 
antidepressant effects of sleep 
deprivation therapy correlates with 
serum BDNF changes in major 
depression. Brain Research Bulletin. 
2009;80(3):158-162
[111] Vgontzas AN, Mastorakos G, 
Bixler EO, Kales A, Gold PW, Chrousos 
GP. Sleep deprivation effects on 
the activity of the hypothalamic-
pituitary-adrenal and growth axes: 
Potential clinical implications. Clinical 
Endocrinology. 1999;51(2):205-215
[112] Arce VM, Devesa P, Devesa J. Role 
of growth hormone (GH) in the treatment 
on neural diseases: From neuroprotection 
to neural repair. Neuroscience Research. 
2013;76(4):179-186. DOI: 10.1016/j.
neures.2013.03.014
17
Neuroprotection, Photoperiod, and Sleep
DOI: http://dx.doi.org/10.5772/intechopen.85013
[113] Arámburo C, Alba-Betancourt 
C, Luna M, Harvey S. Expression and 
function of growth hormone in the 
nervous system: A brief review. General 
and Comparative Endocrinology. 
2014;203:35-42. DOI: 10.1016/j.
ygcen.2014.04.035
[114] Pereira JC Jr, Andersen ML. The 
role of thyroid hormone in sleep 
deprivation. Medical Hypotheses. 
2014;82(3):350-355
[115] Bunevicius A, Iervasi G, 
Bunevicius R. Neuroprotective 
actions of thyroid hormones and 
low-T3 syndrome as a biomarker 
in acute cerebrovascular disorders. 
Expert Review of Neurotherapeutics. 
2015;15(3):315-326. DOI: 
10.1586/14737175.2015.1013465
[116] Trivedi MS, Holger D, Bui AT, 
Craddock TJA, Tartar JL. Short-term 
sleep deprivation leads to decreased 
systemic redox metabolites and 
altered epigenetic status. PLoS One. 
2017;12(7):e0181978. DOI: 10.1371/
journal.pone.0181978
[117] Meier-Ewert HK, Ridker PM, Rifai 
N, Regan MM, Price NJ, Dinges DF, 
et al. Effect of sleep loss on C-reactive 
protein, an inflammatory marker of 
cardiovascular risk. Journal of the 
American College of Cardiology. 
2004;43(4):678-683
[118] Voderholzer U, Fiebich BL, 
Dersch R, Feige B, Piosczyk H, 
Kopasz M, et al. Effects of sleep 
deprivation on nocturnal cytokine 
concentrations in depressed patients 
and healthy control subjects. The 
Journal of Neuropsychiatry and Clinical 
Neurosciences. 2012;24(3):354-366
[119] Gil-Lozano M, Hunter PM, Behan 
LA, Gladanac B, Casper RF, Brubaker 
PL. Short-term sleep deprivation with 
nocturnal light exposure alters time-
dependent glucagon-like peptide-1 and 
insulin secretion in male volunteers. 
American Journal of Physiology. 
Endocrinology and Metabolism. 
2016;310(1):E41-E50. DOI: 10.1152/
ajpendo.00298.2015
